SBRA250117P20000
- 2.71
- 0.000.00%
Sabra Health Care REIT Inc Newsroom
Sabra Healthcare REIT Raised to Market Outperform From Market Perform by JMP Securities
Sabra Health Care REIT Analyst Ratings
JMP Securities Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Announces Target Price $20
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Cuts Target Price to $20
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Mizuho Securities Downgrades Sabra Health Care REIT Inc(SBRA.US) to Hold Rating, Raises Target Price to $20
Sabra Health Care REIT Analyst Ratings
BofA Securities Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $21
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Raises Target Price to $21
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating
Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $18
Sabra Health Care REIT Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Wells Fargo Upgrades Sabra Health Care to Overweight From Equalweight, Adjusts Price Target to $20 From $16
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Maintains Target Price $18
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Sabra Healthcare REIT Price Target Raised to $17.00/Share From $15.00 by Scotiabank
Sabra Health Care REIT Analyst Ratings